YASMIN NURU: Open Payments
NPI 1508317884 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 36 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $410 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| PFIZER INC. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $84 |
| Amgen Inc. | 3 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| INTUITIVE SURGICAL, INC. | 1 | $30 |
| Dexcom, Inc. | 1 | $25 |
Products named: AIRSUPRA, CAPLYTA, Ozempic, OTEZLA, TZIELD, Wegovy, NEXLETOL, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
